Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06611462 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair

Study acronym: STRONG-Hernia
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Bispebjerg Hospital
48 trials monitored
See 2 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
The five risky lifestyles Smoking, Nutrition (obesity and malnutrition), risky Alcohol intake, and Physical inactivity (SNAP) are common in surgical patients and associated with worse postoperative outcomes. Mono-factor interventions targeting and improving these risky lifestyles have been shown to reduce the risk at surgery, but there is a lack of systematic assessment of all five lifestyles of the patient before surgery and related optimization. This study aims to evaluate the effect of intensive combined lifestyle interventions (the STRONG programme) compared with treatment as usual in patients undergoing ventral hernia repair on postoperative complications, health, and costs on short and longer term. The hypothesis is that the STRONG programme will halve the complication rates within 30 days.
Trial Details
NCT Number NCT06611462
Lead Sponsor Bispebjerg Hospital
Collaborators: Copenhagen University Hospital at Herlev, Zealand University Hospital, Holbaek Sygehus
Conditions
(from sponsor)		 Ventral Hernia, Surgery, Risk Reduction, Lifestyle, Postoperative Complications, Prehabilitation
Related terms Alcohol Drinking, Hernia, Ventral, Malnutrition, Obesity, Postoperative Complications, Risk Reduction Behavior, Sedentary Behavior, Smoking
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov